stella
beta
A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants — Stella
Recruiting
Back to Healthy Volunteers trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United Kingdom
Quotient Sciences, Nottingham, Nottinghamshire
View full record on ClinicalTrials.gov